Table 2 Effects of DE exposure on the catecholamine system of GD28 fetuses
|  | Control | Exposed | Effects of DE exposure | Effects of Sex | Exposure × Sex | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Male (n = 4) | Female (n = 4) | Male (n = 4) | Female (n = 4) | F (1,15) | p-value | F (1,15) | p-value | F (1,15) | p-value | |
DA (fmol/mg) | 274.9 ± 27.59 | 276.1 ± 37.85 | 389.7 ± 45.00 | 341.9 ± 41.79 | 3.502 | 0.088 | 0.525 | 0.484 | 0.262 | 0.619 |
DOPAC (fmol/mg) | 212.1 ± 56.13 | 212.1 ± 43.34 | 346.0 ± 122.38 | 460.3 ± 84.89 | 2.451 | 0.146 | 0.453 | 0.515 | 1.308 | 0.277 |
HVA (fmol/mg) | 222.6 ± 32.11 | 280.4 ± 32.21 | 514.1 ± 71.17 | 412.0 ± 134.76 | 2.761 | 0.125 | 0.357 | 0.562 | 0.311 | 0.588 |
DOPAC/DA | 0.789 ± 0.240 | 0.789 ± 0.147 | 0.857 ± 0.247 | 1.33 ± 0.104 | 0.738 | 0.409 | 1.644 | 0.226 | 0.612 | 0.115 |
HVA/DA | 0.810 ± 0.084 | 1.066 ± 0.214 | 1.315 ± 0.068 | 1.158 ± 0.247 | 0.411 | 0.534 | 0.016 | 0.901 | 0.612 | 0.451 |
(DOPAC+HVA)/DA | 1.599 ± 0.290 | 1.855 ± 0.303 | 2.173 ± 0.307 | 2.488 ± 0.348 | 0.854 | 0.375 | 0.879 | 0.369 | 0.557 | 0.471 |
NA (fmol/mg) | 414.7 ± 14.90 | 488.8 ± 45.88 | 304.0 ± 54.32 | 437.1 ± 145.76 | 1.945 | 0.191 | 1.808 | 0.206 | 0.431 | 0.525 |
MHPG (fmol/mg) | 126.9 ± 17.15 | 94.45 ± 24.17 | 135.0 ± 31.76 | 137.9 ± 78.42 | 0.613 | 0.450 | 0.099 | 0.759 | 0.071 | 0.794 |
MHPG/NA | 0.304 ± 0.36 | 0.192 ± 0.039 | 0.469 ± 0.102 | 0.277 ± 0.091 | 6.466 | 0.027* | 5.416 | 0.040* | 1.241 | 0.289 |